74 related articles for article (PubMed ID: 26156090)
21. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
22. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
23. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
[TBL] [Abstract][Full Text] [Related]
24. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
Karaferic A; Jovanovic D; Jelic S
J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Erkinheimo TL; Sivula A; Lassus H; Heinonen M; Furneaux H; Haglund C; Butzow R; Ristimäki A
Gynecol Oncol; 2005 Oct; 99(1):14-9. PubMed ID: 16126263
[TBL] [Abstract][Full Text] [Related]
26. Ovarian tumors. A review.
Scully RE
Am J Pathol; 1977 Jun; 87(3):686-720. PubMed ID: 194486
[No Abstract] [Full Text] [Related]
27. Gonadal malignancy in gonadal dysgenesis: papillary pseudomucinous cystadenocarcinoma in a patient with Turner's syndrome.
Goldberg MB; Scully AL
J Clin Endocrinol Metab; 1967 Mar; 27(3):341-7. PubMed ID: 4290319
[No Abstract] [Full Text] [Related]
28. Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.
Lenhard M; Lennerová T; Ditsch N; Kahlert S; Friese K; Mayr D; Jeschke U
Histopathology; 2011 May; 58(6):990-4. PubMed ID: 21585434
[No Abstract] [Full Text] [Related]
29. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract][Full Text] [Related]
30. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
Yoshida H; Sumi T; Zhi X; Yasui T; Honda K; Ishiko O
Anticancer Res; 2011 Apr; 31(4):1271-7. PubMed ID: 21508375
[TBL] [Abstract][Full Text] [Related]
31. [Gonadal tumors in women with negative sex chromatin].
Savitskiĭ GA
Vopr Onkol; 1968; 14(3):86-9. PubMed ID: 4297515
[No Abstract] [Full Text] [Related]
32. Pulmonary-type adenocarcinoma and signet ring mucinous adenocarcinoma arising in an ovarian dermoid cyst: report of a unique case.
Boyd C; Patel K; O'Sullivan B; Taniere P; McCluggage WG
Hum Pathol; 2012 Nov; 43(11):2088-92. PubMed ID: 23026196
[TBL] [Abstract][Full Text] [Related]
33. [Polysaccharides in epithelial mucinous ovarian neoplasms].
Malarewicz A
Ginekol Pol; 1979 Jun; 50(6):527-30. PubMed ID: 225242
[No Abstract] [Full Text] [Related]
34. Fine needle aspiration of a metastatic mucinous tumour of the thyroid gland from ovarian adenocarcinoma: a potential pitfall in the differential diagnosis of thyroid neoplasms.
D'Antonio A; Addesso M; Marsilia GM; Boscaino A
Cytopathology; 2007 Aug; 18(4):262-4. PubMed ID: 17635164
[No Abstract] [Full Text] [Related]
35. [Low-grade serous, mucinous carcinoma].
Nakayama K; Kyo S
Gan To Kagaku Ryoho; 2015 Feb; 42(2):179-82. PubMed ID: 25834916
[No Abstract] [Full Text] [Related]
36. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
37. Fascin and EMMPRIN expression in primary mucinous tumors of ovary: a tissue microarray study.
Alici O; Kefeli M; Yildiz L; Baris S; Karagoz F; Kandemir B
Pathol Res Pract; 2014 Dec; 210(12):934-8. PubMed ID: 25155376
[TBL] [Abstract][Full Text] [Related]
38. Giant mucinous ovarian tumor with low malignant potential with foci of well-differentiated mucinous adenocarcinoma masked by massive obesity. A case report.
Poole SY; Malone JM; Jacques SM; James A
J Reprod Med; 1994 Dec; 39(12):982-4. PubMed ID: 7884758
[TBL] [Abstract][Full Text] [Related]
39. Epiregulin as a marker for the initial steps of ovarian cancer development.
Amsterdam A; Shezen E; Raanan C; Slilat Y; Ben-Arie A; Prus D; Schreiber L
Int J Oncol; 2011 Nov; 39(5):1165-72. PubMed ID: 21769422
[TBL] [Abstract][Full Text] [Related]
40. Mucinous adenocarcinoma and clear cell adenocarcinoma arising in separate ovaries.
Kojiro M; Hosokawa Y; Abe H; Mitamura T
Arch Pathol Lab Med; 1983 Jan; 107(1):47. PubMed ID: 6293404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
